Protagonist Therapeutics, Inc.
ANALOGUES OF HEPCIDIN MIMETICS WITH IMPROVED IN VIVO HALF LIFES
Last updated:
Abstract:
The present invention provides hepcidin analogues with improved in vivo half lives, and related pharmaceutical compositions and methods of use thereof.
Status:
Application
Type:
Utility
Filling date:
1 Oct 2020
Issue date:
20 May 2021